These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats]. Liu X, Xu YK, Huang QL, Wu YK. Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574 [Abstract] [Full Text] [Related]
10. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Clin Imaging; 2008 Dec; 32(6):453-9. PubMed ID: 19006774 [Abstract] [Full Text] [Related]
11. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis. Mayerhoefer ME, Breitenseher M, Amann G, Dominkus M. Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302 [Abstract] [Full Text] [Related]
18. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [Abstract] [Full Text] [Related]
19. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI. Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317 [Abstract] [Full Text] [Related]